Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 04:00PM ET
0.8641
Dollar change
-0.0502
Percentage change
-5.49
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsU.S. Return% 1Y-44.33% Shs Outstand Perf Week-5.41%
SponsorAmplify Investments ETF Type Tagsequity Return% 3Y-46.04% Total Holdings26 Perf Month-4.71%
Fund Family Bond Type Tagscannabis Return% 5Y- AUM73.60M Perf Quarter-41.22%
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y-48.58%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-47.95%
Active/Passive Quant Type Tags- Flows% 1M7.93% 52W Range0.90 - 2.45 Perf YTD-46.62%
Dividend TTM0.07 (8.54%) ESG Type Tags- Flows% 3M7.93% 52W High-64.73% Beta1.00
Dividend Ex-DateSep 27, 2024 Dividend Type Sector/Theme Flows% YTD16.05% 52W Low-3.99% ATR (14)0.05
Expense0.75% Structure Type Region Flows% 1Y RSI (14)28.35 Volatility4.09% 5.30%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.44 Prev Close0.91
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume140.49K Price0.86
SMA20-12.31% SMA50-30.82% SMA200-47.07% Trades Volume62,482 Change-5.49%
ETFMG U.S. Alternative Harvest ETF seeks income and long-term growth of capital. The fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the "Cannabis Business" in the United States, and in derivatives that have economic characteristics similar to such securities. It will will concentrate at least 25% of its investments in the Pharmaceuticals industry and Equity Real Estate Investment Trusts (REITs) industry groups. The fund is non-diversified.